Clinicopathological Characteristics and Predictive Clinical Features of Lacrimal Gland Lesions
DOI:
https://doi.org/10.35749/oi.v52i1.102093Keywords:
Lacrimal gland lesions, Proptosis, Histopathology, Orbital tumor, Inflammatory lacrimal disorderAbstract
Introduction: Lacrimal gland tumors encompass a wide spectrum of benign, malignant and inflammatory conditions. Understanding the clinico-demographic profile and histopathological findings is crucial for early detection, determining appropriate treatment strategies and improving patient outcomes. Methods: This was a retrospective observational study of patient with lacrimal gland lesions diagnosed at the Reconstructive Oculoplastic and Oncology department at a tertiary care hospital in Central Java. Thirty-nine patients with biopsy-proven lesions between January 2021 and December 2024 were included. Clinical characteristics including age, sex, laterality, symptom duration, proptosis, lagophthalmos, and ocular motility restriction were evaluated. Histopathological diagnoses were categorized into benign, malignant, and inflammatory lesions. Statistical analyses were performed to assess associations between clinical variables, sex, and tumor classification. Results: A total 47 eyes of 39 patients were retrospectively reviewed. The mean age of patients was 46.15 ± 20.27 years (range 2–76), with 48.7% male and 51.3% female. Malignant tumors were more frequent in patients older than 60 years (69.2%), while benign tumors were more common in patients aged 40–59 years (60.0%). Histopathological analysis demonstrated that lymphoid and inflammatory disorders were the most common lesions. Inflammatory disorders consisted of dacryoadenitis and systemic inflammatory disease (sarcoidosis). Proptosis and shorter symptom duration were significantly associated with malignancy, whereas bilateral involvement was significantly associated with inflammatory disorders. No statistically significant difference in tumor classification was observed between male and female patients. Conclusion: Lymphoid and inflammatory disorders were the most prevalent lacrimal gland lesions. Identifying clinical markers such as proptosis, symptom duration, laterality can assist in early malignancy detection and guide management decisions effectively. This study is limited by its retrospective design, single-center setting, and small sample size, which may introduce selection bias and limit generaizability.
Downloads
References
1.Andreasen S, Esmaeli B, von Holstein SL. An update on tumors of the lacrimal gland. Asia-Pac J Ophthalmol. 2017;6(2):159–172.
2.Fay A, Dolman PJ. Disease and disorders of the orbit and ocular adnexa. Edinburgh: Elsevier; 2017.
3.Gurung J, Saiju R. A clinicopathological features and treatment of lacrimal gland tumors at a tertiary eye hospital in Nepal. Ann Med Surg. 2025;87(1):1833–1837.
4.Gao Y, Moonis G, Cunnane ME, Eisenberg RL. Lacrimal gland masses. AJR Am J Roentgenol. 2013 Sep;201(3):W371-81.
5.Rasmussen P, Ralfkiaer E, Prause JU, Sjö LD, Siersma VD, Heegaard S. Malignant lymphoma of the lacrimal gland: a nation-based study. Arch Ophthalmol. 2011;129(10):1275–1280. doi:10.1001/archophthalmol.2011.270.
6.Perez DE, Pires FR, Almeida OP, Kowalski LP, Pinto CA, Graner E. Epithelial lacrimal gland tumors: a clinicopathological study of 18 cases. Otolaryngol Head Neck Surg. 2006;134(2):321–325.
7.Santos RR, Damasceno RW, de Pontes FS, Cursino SR, Manso PG, Marinò GC, et al. Ten-year follow-up of a case series of primary epithelial neoplasms of the lacrimal gland: clinical features, surgical treatment and histopathological findings. Arq Bras Oftalmol. 2010;73(1):33–39.
8.Shields JA, Shields CL. Lacrimal gland tumors: clinical features and classification. Curr Opin Ophthalmol. 2017;28(5):430–436.
9.Alkatan HM. Clinicopathological patterns of lacrimal gland lesions: a 10-year review. Saudi J Ophthalmol. 2018;32(1):45–49.
10.Qian J, Ni J, Yuan Y, Zhang S, Gan L, Zhang J, et al. Clinicopathological analysis of 582 cases of lacrimal gland lesions. Int J Ophthalmol. 2021;14(5):718–723.
11.Van der Wal JE, de Visscher JG, Rose GE. Malignant epithelial tumors of the lacrimal gland. Orbit. 2019;38(3):208–214.
12.Mombaerts I, Ramberg I, Coupland SE, Heegaard S. Diagnostic challenges in orbital lymphoma. Surv Ophthalmol. 2020;65(4):411–426.
13.Woo KI, Kim YD, Sa HS, Esmaeli B. Imaging and clinical markers predictive of lacrimal gland malignancy. Br J Ophthalmol. 2019;103(2):113–118.
14.Ramos D, de Abreu EB, Cruz AA. Bilateral lacrimal gland disease: clinical features and differential diagnosis. Ocul Immunol Inflamm. 2023;31(2):253–260.
15.Plaza JA, Garrity JA, Dogan A, Ferry JA, Deshpande V. Histologic features of IgG4-related disease in the orbit. Mod Pathol. 2020;33(3):435–442.
16.Ramos D, de Abreu EB, Cruz AA. Bilateral dacryoadenitis: diagnostic approach. Ocul Immunol Inflamm. 2023;31(2):253–260.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Yossi Eriska, Raja Erinda, Trilaksana Nugroho

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.